Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction - Summary - MDSpire

Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction

  • By

  • Caroline James

  • Vendula Belackova

  • Wendy Machin

  • Olivia Thackeray

  • Louisa Jansen

  • Danielle Resiak

  • Nina Hutchinson

  • Ian Anderson

  • Nicholas Rich

  • Phillip Read

  • June 10, 2026

  • 0 min

Share

Objective:

To assess the impact of reintroducing winged infusion sets and larger-volume syringes in Needle and Syringe Programs in New South Wales, Australia.

Approach:
    Key Findings:
    • Specify the number of survey respondents (18) for clarity.
    Interpretation:

    Remove unsupported conclusions about health equity.

    Limitations:
    • The study is based on self-reported client outcomes, which may introduce bias.
    • The audit period is relatively short, limiting long-term outcome assessment.
    Conclusion:

    Revise to avoid unsupported claims about addressing gaps in harm reduction.

    Sources:

Original Source(s)

Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction

  • by Caroline James, Vendula Belackova, Wendy Machin, Olivia Thackeray, Louisa Jansen, Danielle Resiak, Nina Hutchinson, Ian Anderson, Nicholas Rich, Phillip Read

  • June 10, 2026

Related Content

Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary

Correction: Transcriptomic and bioinformatics analysis reveals the host response feature and potential treatment strategy of patients with dengue fever

Development and validation of a machine learning model for predicting stroke-associated pneumonia in older patients with acute ischemic stroke